About this trial
This study investigates the effect of threshold inspiratory muscle training on diaphragm thickness and diaphragm excursion, measured using ultrasonography, in patients with stable chronic obstructive pulmonary disease (COPD).
Eligibility criteria
Qualifiers
Patients with a COPD GOLD stage 2
Age 40-59 years
Maximal Inspiratory Pressure (MIP) value of less than 70 cmH₂O or below the lower limit of normal for their age and gender
Clinically stable for at least 4 weeks prior to the study
Disqualifiers
Patients with contraindications to Inspiratory Muscle Training or spirometry (e.g., recent thoracic or abdominal surgery, pneumothorax, or history of spontaneous pneumothorax).
Patients participating in other structured respiratory muscle training or pulmonary rehabilitation programs concurrently that could confound the results
Patients undergoing other therapies that may affect diaphragmatic muscle measurement results, such as electrical diaphragmatic stimulation
Trial design
Treatments tested in this trial
- Threshold Inspiratory Muscle Training
- Philips Respironics Threshold IMT device
Treatment groups
Locations
Sponsors and collaborators
Universitas Padjadjaran
Lead sponsor
Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
Collaborator